Metal labeled peptides for diagnostic imaging in cancer

Informacje na temat projektu

Identyfikator umowy o grant: QLK3-CT-2000-40562

Projekt został zamknięty

Data rozpoczęcia 15 Maja 2000

Data zakończenia 14 Maja 2001

Finansowanie w ramach

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Koszt całkowity € 30 000,00

Wkład UE € 22 500,00

Koordynowany przez

INBIOS
Italy

Cel

The research project foresees the development of new molecular entities based onmetal-labeled peptides and peptidomimetics able to target with high affinity and selectivity receptor sites overexposed in human tumours. The receptors identified as the most attractive targets for the engineering of novel diagnostic tools are cholecystokinin and foliate. The new molecules will be used as diagnostic probes in nuclear medicine and magnetic resonance imaging depending upon the coordinated metal. The development of prototype contrast agents suitable for clinical diagnosis costumers in humans is the final goal.

Dziedzina nauki

• natural sciences › biological sciences › biochemistry › biomolecules
• medical and health sciences › clinical medicine › radiology › nuclear medicine
• medical and health sciences › clinical medicine › oncology
• engineering and technology › medical engineering › diagnostic imaging › magnetic resonance imaging

Program(-y)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Temat(-y)

• 1.1.1.-3. - Key action The "Cell factory"

Zaproszenie do składania wniosków

Data not available

System finansowania

EAW - Exploratory awards

Koordynator

INBIOS

• Wkład UE: Brak danych
• Adres: Via A. Olivetti, 1 ; 80078 POZZUOLI ; Włochy
• Koszt całkowity: Brak danych

Uczestnicy (1)

ISOGEN BIOSCIENCE BV

Niderlandy

• Wkład UE: Brak danych
• Adres: Industrieweg 68 ; 3606 AS MAARSSEN
• Koszt całkowity: Brak danych